Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet COREFLUX 600 ULS/2ml solution for injection
- Product code:
- W60954001
- Quantity:
- 10
- Indicated for:
- vascular disease; thrombosis prevention
- Route of administration:
- injectable
- Substance:
- sulodexide (anticoagulant)
- ATC
- B01AB11 — Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Heparin group
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.
Sulodexide is a medication primarily used for the treatment and prevention of vascular conditions, especially those involving microcirculation. It is a mixture of glycosaminoglycans, mainly composed of low-molecular-weight heparin and dermatan sulfate, with antithrombotic, profibrinolytic, and vasculoprotective properties.
Sulodexide is indicated for the treatment of chronic venous insufficiency, peripheral arterial disease, diabetic retinopathy, and diabetic nephropathy. It is also used to prevent thrombosis and vascular complications in high-risk patients.
Side effects are rare but may include allergic reactions, gastrointestinal disturbances (such as nausea or diarrhea), and, in very rare cases, bleeding. Patients should inform their doctor about any concurrent anticoagulant therapy, as sulodexide may increase the risk of bleeding.
Sulodexide should be used with caution in patients with coagulation disorders or those taking other anticoagulant medications. Periodic monitoring of coagulation parameters may be necessary during treatment.
Sulodexide is indicated for the treatment of chronic venous insufficiency, peripheral arterial disease, diabetic retinopathy, and diabetic nephropathy. It is also used to prevent thrombosis and vascular complications in high-risk patients.
Side effects are rare but may include allergic reactions, gastrointestinal disturbances (such as nausea or diarrhea), and, in very rare cases, bleeding. Patients should inform their doctor about any concurrent anticoagulant therapy, as sulodexide may increase the risk of bleeding.
Sulodexide should be used with caution in patients with coagulation disorders or those taking other anticoagulant medications. Periodic monitoring of coagulation parameters may be necessary during treatment.
General data about COREFLUX 600 ULS/2ml
- Substance:
- sulodexide
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W60954001
- Concentration:
- 600ULS / 2ml
- Pharmaceutical form:
- solution for injection
- Quantity:
- 10
- Product type:
- Generic medicine
- Price:
- 77.60 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for sulodexide
Concentrations available for sulodexide
- 250ULS
- 600ULS/2ml
Compensation lists for COREFLUX 600 ULS/2ml Sanience
B - Sublist B with 50% discount from the reference price
- Price
- 77.60 RON
- Copayment
- 38.80 RON
- Patient
- 38.80 RON